Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Owen Mumford

Owen Mumford Ltd. is an industry leader in the medical device market with a diverse product range including advanced ... read more Featured Products: More products

Download Mobile App





Owen Mumford Presents Cutting-Edge Capillary Blood Sampling Devices for POC Testing

By LabMedica International staff writers
Posted on 15 Nov 2022

Owen Mumford (Oxford, UK) is once again exhibiting at this year’s MEDICA in Düsseldorf, Germany where it is presenting tomorrow’s medical device technology today. Attracting several thousand exhibitors from more than 50 countries, MEDICA is the world’s largest event for the medical sector, where each year, leading individuals from the fields of business, research, and politics converge alongside tens of thousands of decision-makers.

At MEDICA 2022, Owen Mumford is showcasing its pioneering products from three different ranges: safety pen needles, venous blood collection set and capillary blood sampling devices. The company’s portfolio of safety pen needles for insulin injections includes the Unifine SafeControl device which is designed to protect healthcare professionals, balancing both safety and control during the injection process. Compatible with all major brands of injection pens, it is available in a variety of sizes and features a manual push tab for easy, one-handed activation of the safety mechanism. It has both a visual and audible confirmation that the safety mechanism has been activated, making it a dual safety pen needle.

Among Owen Mumford’s featured products at MEDICA is its Unistik Touch safety lancet featuring ground-breaking comfort zone technology which helps to minimize the pain of capillary blood sampling. Unistik Touch safety lancet is designed to make capillary sampling as simple and seamless as possible. With one-touch activation, users can simply press the device against the sample site, allowing it to activate automatically under pressure. Once activated, the needle retracts into the body of the device, minimizing the risk of re-use, cross-infection and injury. At MEDICA 2022, Owen Mumford is also showcasing its recently launched venous blood collection portfolio consisting of new devices such as, the Unistik ShieldLock and Unistik VacuFlip. This range provides safety, comfort and quality for healthcare professionals when performing venous blood collection procedures.

Related Links:
Owen Mumford 

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.